Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case-control study

• প্রধান লেখক: Xiaqing Zhang (লেখক), Yao Wang (লেখক), Chengyang Hu (লেখক), Pengpeng Xu (লেখক), Liguo Ma (লেখক), Lei Liu (লেখক), Jie Sun (লেখক), Yang Liu (লেখক), Hui Yang (লেখক), Fan Pan (লেখক), Jieying Hu (লেখক), Chengsong Cao (লেখক), Kai Cheng (লেখক), Dawei Gao (লেখক), Yong Lyu (লেখক), Wei Qin (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Real-world evidence on the effectiveness of COVID-19 vaccines marketed in China against the Omicron BA.2.2 variant remains scarce. A case-control study was conducted to estimate the vaccine effectiveness (VE) of COVID-19 vaccines marketed in China (inactivated vaccines, an Ad5-nCoV vaccine, and a re...